CIP2A-BP inhibits the oncogene CIP2A, thereby inhibiting multiple oncogenic signaling pathways and CIP2A-BP-abrogated lung metastases in the MMTV-PyMT mouse breast cancer model [69]. Here, CIP2A is linked to breast carcinoma.